BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
<p><strong>Background and Aims</strong></p> The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is linked to the presence of pancreatic cancer stem-like cells (CSCs) that respond poorly to current chemotherapy regimens. The epigenetic mechanisms regulating CSCs ar...
Asıl Yazarlar: | Feng, Y, Cai, L, Pook, M, Liu, F, Chang, C-H, Mouti, MA, Nibhani, R, Militi, S, Dunford, J, Philpott, M, Fan, Y, Fan, G-C, Liu, Q, Qi, J, Wang, C, Hong, W, Morgan, H, Wang, M, Sadayappan, S, Jegga, AG, Oppermann, U, Wang, Y, Huang, W, Jiang, L, Pauklin, S |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Elsevier
2023
|
Benzer Materyaller
-
SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell cycle inhibitors to guide tissue formation
Yazar:: Militi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2024) -
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics
Yazar:: Mouti, MA, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling
Yazar:: Militi, S, ve diğerleri
Baskı/Yayın Bilgisi: (2023) -
TGFB1/INHBA homodimer/nodal-SMAD2/3 signaling network: a pivotal molecular target in PDAC treatment
Yazar:: Abdel Mouti, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics
Yazar:: Mai Abdel Mouti, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)